Stock listing
NASDAQ:WWB Windward Bio Group AG Stock
Home listing (NASDAQ) of Windward Bio Group AG
Follow Windward Bio Group AG into a list and get an email when it puts out news.
Share price · NASDAQ:WWB
$24.29 USD +1.64 (+7.3%)
Close on Nov 20, 2026
- Day range
- $22.47 – $26.20 USDNov 20, 2026
- Volume
- 158,585 sharesNov 20, 2026
- Market cap
- $1.41B USDAt the close on Nov 20, 2026 · price × 58.04M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:WWB · Home | $24.29 USD | +1.645 (+7.3%) | 158,585 | $24.49 | $26.20 | $22.47 | $22.64 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Nov 12, 2026 – Nov 20, 2026 · NASDAQ:WWB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $24.29 | +1.645 | +7.3% | $24.49 | $26.20 | $22.47 | 158,585 | |
| $22.64 | -3.12 | -12.1% | $25.51 | $29.92 | $21.02 | 518,148 | |
| $25.76 | -4.28 | -14.2% | $29.67 | $29.67 | $21.38 | 246,200 | |
| $30.04 | +1.54 | +5.4% | $25.00 | $32.00 | $22.50 | 237,700 | |
| $28.50 | +11.50 | +67.6% | $18.35 | $33.99 | $18.35 | 1,279,000 | |
| $17.00 | — | — | $17.00 | $17.00 | $17.00 | 0 |
- Ticker
- NASDAQ:WWB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Windward Bio to Participate at the Jefferies London Global Healthcare Conference
Latest news
Windward Bio to Participate at the Jefferies London Global Healthcare Conference
Nov 17, 2026
Closed $22.64 (-12.1%) on Nov 18, 2026
Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nov 16, 2026
Closed $25.76 (-14.2%) on Nov 17, 2026
Windward Bio Lists on Nasdaq, Shares Up 68% on Debut
Nov 16, 2026
Closed $30.04 (+5.4%) on Nov 16, 2026
Windward Bio Group AG on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 3 in the last 12 months · 3 in all · newest Nov 17, 2026 · oldest 2026
Where Windward Bio Group AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:WWB · Home listing · This page | NASDAQ | United States | USD |
| BOATS:WWB | BOATS | United States | USD |
Team and board
Officers
| Officer | Role |
|---|---|
| Luca Santarelli | Chief Executive Officer, Founder & Chair of the Board |
| Claudia D’Augusta | Chief Financial Officer |
| Sandip Kapadia | Experienced Life Sciences Board Member and Chief Financial Officer |
| Kevin Harris | Chief Operating Officer |
| Scott Applebaum | Chief Legal & Corporate Development Officer |
| Martine Mazzetti | Chief of Staff |
| Michael Steininger | Chief Human Resources Officer |
| Omar Khwaja | Chief Medical Officer |
| Otello Stampacchia | Founder & Managing Director, Omega Fund Management, LLC |
Board
| Director | Role |
|---|---|
| Luca Santarelli | Chief Executive Officer, Founder & Chair of the Board |
Financings
| Raise | Date |
|---|---|
| Public offering of common shares Closed: US$17 a share · Jefferies +3 Dealers: Jefferies (co-lead), TD Cowen (co-lead), Piper Sandler (co-lead), UBS Investment Bank (co-lead) | Nov 16, 2026 |
| Private placement of common shares and pre-funded warrants Closed: US$50M raised Buyers: Sanofi Foreign Participations B.V. (1,532,691 common shares and pre-funded warrants to purchase 1,408,485 common shares for $50.0 million) | Nov 16, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$17.00 a share on Nov 12, 2026.
- Price
- US$17.00 a share
- Shares offered
- 10,294,117 common shares
- Offering size
- US$175 million
- Underwriters' option
- Up to 1,544,117 more shares
- Listing
- WWB on the Nasdaq Global Select Market
- Underwriters
- Jefferies, TD Cowen, Piper Sandler, UBS Investment Bank · In the order on the cover
- Shares delivered
- On or about Nov 16, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 24, 2026 |
| Filed publicly | Oct 23, 2026 |
| Amended twice | Newest Nov 9, 2026 |
| Shares registered with an exchange | Nov 9, 2026 |
| Declared effective by the SEC | Nov 12, 2026 |
| Final prospectus, with the price | Nov 16, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Nov 16, 2026 |
| FWP · Free writing prospectus | Nov 13, 2026 |
| EFFECT · Notice that a registration is effective | Nov 12, 2026 |
| CERT · Exchange's certificate of listing | Nov 12, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Nov 9, 2026 |
| F-1/A · Registration statement, amended | Nov 9, 2026 |
| F-1/A · Registration statement, amended | Oct 30, 2026 |
| F-1 · Registration statement | Oct 23, 2026 |
| DRS/A · Draft registration statement, amended | Oct 13, 2026 |
| DRS/A · Draft registration statement, amended | Sep 21, 2026 |
All 12 filings
| Filing | Filed |
|---|---|
| DRS/A · Draft registration statement, amended | Aug 27, 2026 |
| DRS · Draft registration statement | Jul 24, 2026 |
Open IPO · From the cover of the final prospectus (424B4) filed Nov 16, 2026
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
All 37 filings
Cap table
Built by 6ix from Windward Bio Group AG’s releases · as of Nov 16, 2026
- Common shares
- 58,038,748
- Fully diluted
- 58,038,748
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 58,038,748 | Nov 16, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 16, 2026 | 58,038,748 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Bonita Other companies: Third Harmonic Bio Inc. (Director · Since at least Aug 11, 2025); ImageneBio, Inc. (Director · Since at least Jul 25, 2025); Prelude Therapeutics Incorporated (Director · Since at least Jun 12, 2025) | Director · Since at least Nov 16, 2026 |
| Claudia D’Augusta | Chief Financial Officer · Since at least Nov 16, 2026 |
| Kevin Harris | Chief Operating Officer · Since at least Nov 16, 2026 |
| Luca Santarelli | Chief Executive Officer, Founder & Chair of the Board · Since at least Nov 16, 2026 |
| Martine Mazzetti | Chief of Staff · Since at least Nov 16, 2026 |
| Michael Steininger | Chief Human Resources Officer · Since at least Nov 16, 2026 |
| Omar Khwaja | Chief Medical Officer · Since at least Nov 16, 2026 |
| Otello Stampacchia | Director · Since at least Nov 16, 2026 |
| Sandip Kapadia | Director · Since at least Nov 16, 2026 |
| Scott Applebaum | Chief Legal & Corporate Development Officer · Since at least Nov 16, 2026 |
Log in to ask 6ix AI your own questions about Windward Bio Group AG.